Intuitive Surgical, Inc. Cash and Cash Equivalents
Intuitive Surgical, Inc. (ISRG) had Cash and Cash Equivalents of $2.76 billion as of 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-21
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.76B.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.01B.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.37B.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $2.81B.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $2.76B 10-Q · filed 2026-07-21 | |
| 2026-03-31 | $2.01B 10-Q · filed 2026-04-22 | |
| 2025-12-31 | $3.37B 10-Q · filed 2026-07-21 | |
| 2025-09-30 | $2.81B 10-Q · filed 2025-10-22 | |
| 2025-06-30 | $3.40B 10-Q · filed 2025-07-23 | |
| 2025-03-31 | $2.57B 10-Q · filed 2025-04-23 | |
| 2024-12-31 | $2.03B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $2.41B 10-Q · filed 2024-10-18 | |
| 2024-06-30 | $3.04B 10-Q · filed 2024-07-19 | |
| 2024-03-31 | $2.84B 10-Q · filed 2024-04-19 | |
| 2023-12-31 | $2.75B 10-K · filed 2025-01-31 | |
| 2023-09-30 | $3.60B 10-Q · filed 2023-10-20 | |
| 2023-06-30 | $3.44B 10-Q · filed 2023-07-24 | |
| 2023-03-31 | $2.14B 10-Q · filed 2023-04-20 | |
| 2022-12-31 | $1.58B 10-K · filed 2024-01-31 | |
| 2022-09-30 | $1.54B 10-Q · filed 2022-10-21 | |
| 2022-06-30 | $1.54B 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $1.10B 10-Q · filed 2022-04-22 | |
| 2021-12-31 | $1.29B 10-K · filed 2023-02-10 | |
| 2021-09-30 | $1.35B 10-Q · filed 2021-10-20 | |
| 2021-06-30 | $1.62B 10-Q · filed 2021-07-21 | |
| 2021-03-31 | $1.40B 10-Q · filed 2021-04-21 | |
| 2020-12-31 | $1.62B 10-K · filed 2022-02-03 | |
| 2020-09-30 | $1.37B 10-Q · filed 2020-10-19 | |
| 2020-06-30 | $2.04B 10-Q · filed 2020-07-23 | |
| 2020-03-31 | $1.22B 10-Q · filed 2020-04-17 | |
| 2019-12-31 | $1.17B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $969.60M 10-Q · filed 2019-10-18 | |
| 2019-06-30 | $790.30M 10-Q · filed 2019-07-22 | |
| 2019-03-31 | $875.70M 10-Q · filed 2019-04-19 | |
| 2018-12-31 | $857.90M 10-K · filed 2020-02-07 | |
| 2018-09-30 | $1.01B 10-Q · filed 2018-10-22 | |
| 2018-06-30 | $1.20B 10-Q · filed 2018-07-20 | |
| 2018-03-31 | $974.70M 10-Q · filed 2018-04-18 | |
| 2017-12-31 | $648.20M 10-K · filed 2019-02-04 | |
| 2017-09-30 | $875.00M 10-Q · filed 2017-10-20 | |
| 2017-06-30 | $696.50M 10-Q · filed 2017-07-21 | |
| 2017-03-31 | $708.60M 10-Q · filed 2017-04-19 | |
| 2016-12-31 | $1.04B 10-K · filed 2018-02-02 | |
| 2016-09-30 | $1.02B 10-Q · filed 2017-10-20 | |
| 2016-06-30 | $1.19B 10-Q · filed 2017-07-21 | |
| 2016-03-31 | $980.50M 10-Q · filed 2017-04-19 | |
| 2015-12-31 | $714.60M 10-K · filed 2018-02-02 | |
| 2015-09-30 | $868.20M 10-Q · filed 2016-10-19 | |
| 2015-06-30 | $915.40M 10-Q · filed 2016-07-20 | |
| 2015-03-31 | $701.10M 10-Q · filed 2016-04-19 | |
| 2014-12-31 | $600.30M 10-K · filed 2018-02-02 | |
| 2014-09-30 | $493.00M 10-Q · filed 2015-10-21 | |
| 2014-06-30 | $507.60M 10-Q · filed 2015-07-22 | |
| 2014-03-31 | $814.00M 10-Q · filed 2015-04-22 | |
| 2013-12-31 | $782.10M 10-K · filed 2017-02-06 | |
| 2013-09-30 | $586.80M 10-Q · filed 2014-10-23 | |
| 2013-06-30 | $432.70M 10-Q · filed 2014-07-24 | |
| 2013-03-31 | $427.50M 10-Q · filed 2014-04-25 | |
| 2012-12-31 | $553.70M 10-K · filed 2016-02-02 | |
| 2012-09-30 | $396.20M 10-Q · filed 2013-10-18 | |
| 2012-06-30 | $484.40M 10-Q · filed 2013-07-22 | |
| 2012-03-31 | $325.90M 10-Q · filed 2013-04-19 | |
| 2011-12-31 | $465.80M 10-K · filed 2015-02-06 | |
| 2011-09-30 | $298.20M 10-Q · filed 2012-10-18 | |
| 2011-06-30 | $382.00M 10-Q · filed 2012-07-23 | |
| 2011-03-31 | $449.80M 10-Q · filed 2012-04-19 | |
| 2010-12-31 | $279.80M 10-K · filed 2014-02-03 | |
| 2010-09-30 | $382.00M 10-Q · filed 2011-10-19 | |
| 2010-06-30 | $420.00M 10-Q · filed 2011-07-20 | |
| 2010-03-31 | $313.60M 10-Q · filed 2011-04-20 | |
| 2009-12-31 | $221.40M 10-K · filed 2013-02-04 | $221.44M 10-K · filed 2010-01-29 |
| 2009-09-30 | $206.10M 10-Q · filed 2010-10-20 | $206.09M 10-Q · filed 2009-10-21 |
| 2009-06-30 | $173.40M 10-Q · filed 2010-07-23 | $173.42M 10-Q · filed 2009-07-23 |
| 2009-03-31 | $96.60M 10-Q · filed 2010-04-20 | |
| 2008-12-31 | $194.60M 10-K · filed 2012-02-06 | $194.62M 10-Q · filed 2009-07-23 |
| 2008-09-30 | $227.61M 10-Q · filed 2009-10-21 | |
| 2008-06-30 | $223.02M 10-Q · filed 2009-07-23 | |
| 2007-12-31 | $122.80M 10-K · filed 2011-02-01 | $122.83M 10-Q · filed 2009-07-23 |
| 2006-12-31 | $34.39M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |